	Effects of immune related adverse events and corticosteroids on the outcome of patients treated with immune checkpoint inhibitors. Sci Rep , Özta, De, Safarov S, Guliyev M, Bedir , Can G, Turna H, Özgüro. PMID: 39984593 [PubMed - indexed for MEDLINE]
	The effect of occupational exposure to welding fumes on trachea, bronchus, and lung cancer: A supplementary analysis of regular occupational exposure and of occasional occupational exposure based on the systematic review and meta-analysis from the WHO/ILO Joint estimates of the work-related burden of disease and Injury. Environ Int Momen NC, Baker MG, Driscoll T, Li J, Martínez-Silveira MS, Turner MC, Viegas S, Villeneuve PJ, Pega F. PMID: 39984224 [PubMed - indexed for MEDLINE]
	Exercise medicine for individuals diagnosed with Lung Cancer: A systematic review and meta-analysis of health outcomes. Lung Cancer Ficarra S, Kang DW, Wilson RL, Gonzalo-Encabo P, Christopher CN, Normann AJ, Lopez P, Laki, Dieli-Conwright CM. PMID: 39983446 [PubMed - as supplied by publisher]
	ENDOLUNG trial, part II. A phase II study of the Akt/mTOR inhibitor and autophagy inducer ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with squamous non-small cell lung cancer. Lung Cancer Bosch-Barrera J, Estévez-García P, Martín-Martorell P, Sabatier R, Nadal E, Sais E, Gascón P, Oaknin A, Rodon J, Lizcano JM, Muñoz-Guardiola P, Fierro-Durán G, Pedrós-Gámez O, Pérez-Montoyo H, Yeste-Velasco M, Cortal M, Pérez-Campos A, Alfón J, Domènech C, Morán T. PMID: 39983444 [PubMed - as supplied by publisher]
	Overall survival according to time-of-day of combined immuno-chemotherapy for advanced non-small cell lung cancer: a bicentric bicontinental study. EBioMedicine Huang Z, Karaboué A, Zeng L, Lecoeuvre A, Zhang L, Li XM, Qin H, Danino G, Yang F, Malin MS, Deng L, Rigal M, Liu H, Chen X, Xu Q, Grimaldi L, Collon T, Wang J, Adam R, Yang N, Duchemann B, Zhang Y, Lévi F. PMID: 39983330 [PubMed - as supplied by publisher]
	Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial. J Clin Oncol Gautschi O, Park K, Solomon BJ, Tomasini P, Loong HH, De Braud F, Goto K, Peterson P, Barker S, Liming K, Oxnard GR, Frimodt-Moller B, Drilon A. PMID: 39983053 [PubMed - as supplied by publisher]
	Burden of Comorbid Conditions Among Individuals Screened for Lung Cancer. JAMA Health Forum Braithwaite D, Karanth S, Slatore CG, Yang JJ, Tammemagi M, Gould MK, Silvestri GA. PMID: 39982715 [PubMed - indexed for MEDLINE]
	Epigenomic Echoes-Decoding Genomic and Epigenetic Instability to Distinguish Lung Cancer Types and Predict Relapse. Epigenomes Baumann AA, Buribayev Z, Wolkenhauer O, Salybekov AA, Wolfien M. PMID: 39982247 [PubMed]
	Telomeres and telomerase in mesothelioma: Pathophysiology, biomarkers and emerging therapeutic strategies (Review). Int J Oncol Andreikos D, Spandidos DA, Georgakopoulou VE. PMID: 39981889 [PubMed - indexed for MEDLINE]
	Clinical significance of 4Â L lymphadenectomy in solid dominant clinical stage I non-small cell lung cancer in the left upper lobe. Jpn J Clin Oncol Watanabe Y, Hattori A, Fukui M, Matsunaga T, Takamochi K, Suzuki K. PMID: 39981827 [PubMed - as supplied by publisher]
	Evaluating the effect of immune checkpoint inhibitor treatment on chronic obstructive pulmonary disease in lung cancer patients. Oncoimmunology Greib A, Zhao S, Ploch M, Henricks J, Easterling R, Moodabagil M, Lopez G, Li M, Goodyear EG, Sharp J, Alahmadi A, Kaufman J, Memmott R, He K, Shields P, Carbone DP, Otterson GA, Presley CJ, Wei L, Owen DH, Ho K. PMID: 39981683 [PubMed - indexed for MEDLINE]
	Clinical and pathological characteristics of pulmonary meningioma: a case report and literature review. J Int Med Res Chang HF, Maimaitiaili N, Huo JF, Sun ZL. PMID: 39981620 [PubMed - indexed for MEDLINE]
	Predictive Value of Neutrophil-to-Lymphocyte Ratio for Immune Checkpoint Inhibitor-Related Myocarditis Among Patients Treated for Non-Small-Cell Lung Cancer. Cancer Innov Xue J, Liu C, Shao J, Wang L, Han Y, Wang J, Wang J. PMID: 39981496 [PubMed]
	Efficacy and safety of first-line PD-1/PD-L1 inhibitor in combination with CTLA-4 inhibitor in the treatment of patients with advanced non-small cell lung cancer: a systemic review and meta-analysis. Front Immunol Zhao H, Huang S, Wu J, Lu Y, Zou Y, Zeng H, Li C, Wang J, Zhang X, Duan S, Liang W. PMID: 39981238 [PubMed - indexed for MEDLINE]
	Association between advanced lung cancer inflammation index and all-cause and cause-specific mortality among asthma patients: a cohort study. Front Nutr Tian TL, Qu XK, Zhang HB, Wang CC, Yuan QQ, Xia J, Cao LF, Liu K. PMID: 39980677 [PubMed]
	Hereditary transthyretin amyloidosis incidentally diagnosed by video-associated lung surgery for lung cancer: A case report. Respir Med Case Rep Itogawa K, Sato S, Yamakawa H, Akasaka K, Amano M, Adachi A, Matsushima H. PMID: 39980614 [PubMed]
	Low Grade Pulmonary Spindle Cell Neoplasm in a 30-Year-Old Asymptomatic Female: A Diagnostic Dilemma: A Case Report. Respirol Case Rep Juarez JE, Rafanan AL, Yap MG. PMID: 39980581 [PubMed]
	Characteristics, treatment patterns, and biomarker testing of patients with advanced RET fusion-positive non-small cell lung cancer in a real-world multi-country observational study: a brief report. Front Oncol Kiiskinen U, Segall G, Bailey H, Forshaw C, Puri T. PMID: 39980547 [PubMed]
	A pelvis MR transformer-based deep learning model for predicting lung metastases risk in patients with rectal cancer. Front Oncol Li Y, Li S, Xiao R, Li X, Yi Y, Zhang L, Zhou Y, Wan Y, Wei C, Zhong L, Yang W, Yao L. PMID: 39980546 [PubMed]
	Perioperative Treatment in EGFR-Mutant Early-Stage Non-Small Cell Lung Cancer: Current Evidence and Future Perspectives. Thorac Cancer Guo X, Liu X, Guo C, Miao Q, Cheng X, Hong X, Li H, Qiu X, Xiang Y, Zheng D, Zhou J, Jiang L, Xu Y, Wang M. PMID: 39980151 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 144889

Page 1 of 7245



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy